Indian Journal of Pharmacy Practice · 2015 · 16 citations · 13 references
MedicineMaternal HealthObstetricsHigh-risk PregnancyMaternal-fetal MedicineWomen's Health PharmacotherapyAntenatal CareAntenatal Risk AssessmentMaternal Medical Complications In PregnancyMaternal Medical ConditionsPregnancyPrenatal CareDrug Use AssessmentDrug Utilization InformationDrug Utilization SurveillanceMaternal Drug SafetyPharmaceutical Exposure During PregnancyPharmacotherapy In PregnancyPrescription Pattern AnalysisTeratogenicity Risk Assessment
Background: Pregnancy is a special physiological condition where the treatment needs a special concern. Moreover, pharmacotherapy during pregnancy is very challenging since only a few medicines have been specifically tested for safety. Objective: The aim of this study was to evaluate the utilization pattern and the teratogenicity risk of the drugs prescribed to pregnant women in Fiche Hospital, Ethiopia. Methods: A retrospective study was conducted by reviewing medical case files of 323 pregnant women, encountered with at least one drug, out of 1876 pregnant women attending antenatal clinic from February 09/2013 to March 09/2014. The prescription pattern was assessed from perspectives of World Health Organization (WHO) core drug use indicators, and the United States Food and Drug Administration (FDA) fetal harm classification. Results: Among 1876 pregnant women who visited ANC clinic, a total of 323 women received 456 medications. The age of the patients was within the range of 16-49 years and the majority of them (77.22%) were within the age group of 20-35 years. The majority of pregnant women (80.47%) visited antenatal care (ANC) during their first trimester gestation. Out of the total drugs prescribed, category A drugs comprised 20.83%, category B (26.34%), category C (24.34%), category C/D (9.65%), category D (9.43%) and category X (1.09%). Percentage of encounter with antibiotics and injectable drugs were 31.8% and 19.30%, respectively. Conclusion: Approximately half of the pregnant women utilized drugs from FDA category C, D and X which are thought to cause fetal harm; therefore, the use of these drugs should be minimized.
13
Prescription drug use in pregnancy
Susan E. Andrade, Jerry H. Gurwitz, Robert L. Davis et al. · American Journal of Obstetrics and Gynecology · 2004 · 559 citations
Drug use in pregnancy; a point to ponder!
Punam D Sachdeva, BG Patel, BK Patel · Indian Journal of Pharmaceutical Sciences · 2009 · 191 citations · Full text
Medicine, Obstetrics, Pharmacology +16
National patterns of medication use during pregnancy
Euni Lee, Mary Maneno, Leah Smith et al. · Pharmacoepidemiology and Drug Safety · 2006 · 94 citations